Paraoxonase 2 (PON2) polymorphisms and development of renal dysfunction in type 2 diabetes: UKPDS 76.

Calle, R; McCarthy, M I; Banerjee, P; Zeggini, E; Cull, C A; Thorne, K I; Wiltshire, S; Terra, S; Meyer, D; Richmond, J; Mancuso, J; Milos, P; Fryburg, D; Holman, R R

Calle, R; McCarthy, M I; Banerjee, P; Zeggini, E; Cull, C A; Thorne, K I; Wiltshire, S; Terra, S; Meyer, D; Richmond, J; Mancuso, J; Milos, P; Fryburg, D; Holman, R R.

Affiliation

Calle R; Pfizer Global Research & Development, Groton, CT, USA.

Diabetologia ; 49(12): 2892-9, 2006 Dec.

Article in En | MEDLINE | ID: mdl-17096118

Subject(s)

Aryldialkylphosphatase/genetics; Diabetes Mellitus, Type 2/genetics; Diabetic Nephropathies/genetics; Polymorphism, Genetic; Albuminuria/genetics; Amino Acid Substitution; Blood Pressure; Creatinine/blood; Creatinine/urine; Diabetes Mellitus, Type 2/blood; Diabetes Mellitus, Type 2/enzymology; Diabetic Nephropathies/blood; Diabetic Nephropathies/enzymology; Disease Progression; Ethnicity; Female; Genotype; Humans; Linkage Disequilibrium; Male; Middle Aged; Polymorphism, Single Nucleotide

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Aryldialkylphosphatase / Diabetes Mellitus, Type 2 / Diabetic Nephropathies Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Diabetologia Year: 2006 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links